Latest News & Updates of Loncom Pharma

Abemaciclib, developed by Eli Lilly, represents a significant advancement in the treatment of advanced or metastatic breast cancer. Its approval in September 2017 by the US FDA marked a new chapter for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HE

Levosimendan, known chemically as a hydrazone, pyridazinone, and nitrile, has emerged as a critical drug in cardiac care. Initially developed in the late 1990s, Levosimendan has carved out a niche in managing acute cardiac conditions that necessitate immediate and potent intervention.

In recent years, a new medication called Elagolix Sodium has emerged as a promising treatment for women suffering from endometriosis and uterine fibroids, offering significant relief from these debilitating conditions.Understanding Elagolix SodiumElagolix sodium is an oral medication that works as a

Darolutamide: A Promising Advancement in Prostate Cancer TreatmentDarolutamide, a next-generation androgen receptor inhibitor, has emerged as a promising therapeutic option for patients with prostate cancer, particularly those with non-metastatic castration-resistant prostate cancer (nmCRPC). This m